Females with Cystic Fibrosis Demonstrate a Differential Response Profile to Ivacaftor Compared with Males

Podobne knjige/članki

• Effectiveness of ivacaftor in cystic fibrosis Patients with non-G551D gating mutations
  od: Guimbellot, Jennifer, et al.
  Izdano: (2018)
• Ivacaftor-treated Patients with Cystic Fibrosis Derive Long-Term Benefit Despite No Short-Term Clinical Improvement
  od: Heltshe, Sonya L., et al.
  Izdano: (2018)
• Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor
  od: Stalvey, Michael S., et al.
  Izdano: (2017)
• Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis
  od: Rowe, Steven M., et al.
  Izdano: (2014)
• Combination Therapy with Lumacaftor–Ivacaftor in Cystic Fibrosis. Keeping It Real
  od: Sala, Marc A., et al.
  Izdano: (2020)